Cytoprotection and healing: Two unequal brethren

Inflammopharmacology

Volumn 5, Issue 4, 1997, Pages 407-414

  Halter, F ^a   Peskar, B ^a   Rainsford, K D ^a   Schmassmann, A ^a  

^a University of Berlin   (Switzerland)

Author keywords

Cytoprotection; NSAIDs; Ulcer

Indexed keywords

LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE; PROTECTIVE AGENT;

ARTICLE; CELL PROTECTION; GASTROINTESTINAL TOXICITY; HUMAN; PEPTIC ULCER; PRIORITY JOURNAL; ULCER HEALING;

EID: 0030779276     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-997-0036-3     Document Type: Article

References (37)

1. 1. F Halter S Hurlimann W Inauen 1992 Pathophysiology and clinical relevance of Helcobacter pylori Yale J Biol Med 65 625 38 1341068 1:STN:280:DyaK2c%2FntVSquw%3D%3D Halter F, Hurlimann S, Inauen W. Pathophysiology and clinical relevance of Helcobacter pylori. Yale J Biol Med. 1992;65:625–38.
2. 2. CJ Hawkey 1990 Non-steroidal anti-inflammatory drugs and peptic ulcers Br Med J. 300 278 84 1:STN:280:DyaK3c7otFOiug%3D%3D 10.1136/bmj.300.6720.278 Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. Br Med J. 1990;300:278–84.
3. 3. DA Peura DY Graham 1994 Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease (editorial) Am J Gastroenterol 89 1137 9 8053422 1:STN:280:DyaK2czjtVChtQ%3D%3D Peura DA, Graham DY. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease (editorial). Am J Gastroenterol. 1994;89:1137–9.
4. 4. HP Armstrong AL Blower 1987 Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration Gut 28 527 532 3596334 1:STN:280:DyaL2s3kvVahsw%3D%3D Armstrong HP, Blower AL. Non-steroidal anti-inflammatory drugs and life-threatening complications of peptic ulceration. Gut. 1987;28:527–532.
5. 5. K Somerville G Faulkner M Langman 1986 Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer Lancet 1 462 4 2869207 10.1016/S0140-6736(86)92927-2 1:STN:280:DyaL287ksFOrug%3D%3D Somerville K, Faulkner G, Langman M. Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer. Lancet. 1986;1:462–4.
6. 6. F Halter B Weber T Huber F Eigenmann MP Frey C Ruchti 1993 Diaphragm disease of the ascending colon. Association with sustained-release diclofenac J. Clin. Gastroenterol. 16 74 80 8421154 10.1097/00004836-199301000-00020 1:STN:280:DyaK3s7jt1aktA%3D%3D Halter, F, Weber B, Huber T, Eigenmann, F, Frey MP, Ruchti C. Diaphragm disease of the ascending colon. Association with sustained-release diclofenac. J. Clin. Gastroenterol. 1993;16:74–80.
7. 7. W Inauen PA Wyss S Kayser 1988 Influence of prostaglandins, omeprazole, and indomethacin on healing of experimental gastric ulcers in the rat Gastroenterology 95 636 41 3396812 1:CAS:528:DyaL1cXlsVehsrs%3D Inauen W, Wyss PA, Kayser S et al. Influence of prostaglandins, omeprazole, and indomethacin on healing of experimental gastric ulcers in the rat. Gastroenterology. 1988;95:636–41.
8. 8. JY Wang S Yamasaki K Takeuchi S Okabe 1989 Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin Gastroenterology 96 393 402 2910759 1:CAS:528:DyaL1MXhtVOqtrw%3D Wang JY, Yamasaki S, Takeuchi K, Okabe S. Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology. 1989;96:393–402.
9. 9. A Robert JE Nezamis C Lancaster AJ Hanchar 1979 Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCVL, NaOH, hypertonic NACl, and thermal injury Gastroenterology 77 433 43 456839 1:CAS:528:DyaE1MXls1yqsLw%3D Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCVL, NaOH, hypertonic NACl, and thermal injury. Gastroenterology. 1979;77:433–43.
10. 10. H Hirose K Takeuchi S Okabe 1991 Effect of indomethacin on gastric mucosal blood flow around acetic acid induced gastric ulcers in rats Gastroenterology 100 1259 65 2013372 1:CAS:528:DyaK3MXktVSns78%3D Hirose H, Takeuchi K, Okabe S. Effect of indomethacin on gastric mucosal blood flow around acetic acid induced gastric ulcers in rats. Gastroenterology. 1991;100:1259–65.
11. 11. DY Graham NM Agrawal SH Roth 1988 Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial Lancet 2 1277 80 2904006 10.1016/S0140-6736(88)92892-9 1:STN:280:DyaL1M%2Fls1CrsQ%3D%3D Graham DY, Agrawal NM, Roth SH. Prevention of NSAID-induced gastric ulcer with misoprostol: multicentre, double-blind, placebo-controlled trial. Lancet. 1988;2:1277–80.
12. 12. A Schmassmann A Tarnawski BM Peskar L Varga B Flogerzi F Halter 1994 Sequential assessment of gastric ulcer healing in rats: reversal of indomethacin-induced effects by omeprazole Am J Physiol 268 G276 85 Schmassmann A, Tarnawski A, Peskar BM, Varga L, Flogerzi B, Halter F. Sequential assessment of gastric ulcer healing in rats: reversal of indomethacin-induced effects by omeprazole. Am J Physiol. 1994;268:G276–85.
13. 13. S Levi RA Goodlad CY Lee 1990 Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing Lancet 336 840 3 1699093 10.1016/0140-6736(90)92341-E 1:CAS:528:DyaK3MXhslyjsLw%3D Levi S, Goodlad RA, Lee CY et al. Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet. 1990;336:840–3.
14. 14. Y Ogihara S Okabe 1993 Mechanism by which indomethacin delays gastric ulcer healing in the rat: Inhibited contraction of the ulcer base Jpn J Pharmacol 61 123 31 8459649 1:CAS:528:DyaK3sXhs1SktLs%3D 10.1254/jjp.61.123 Ogihara Y, Okabe S. Mechanism by which indomethacin delays gastric ulcer healing in the rat: Inhibited contraction of the ulcer base. Jpn J Pharmacol. 1993;61:123–31.
15. 15. DY Graham JL Smith HJ Spjut E Torres 1988 Gastric adaptation studies in humans during continuous aspirin administration Gastroenterology 95 327 33 3260568 1:CAS:528:DyaL1cXkvVGqt7Y%3D Graham DY, Smith JL, Spjut HJ, Torres E. Gastric adaptation studies in humans during continuous aspirin administration. Gastroenterology. 1988;95:327–33.
16. 16. CJ Hawkey RP Walt 1986 Prostaglandins for peptic ulcer. A promise unfulfilled Lancet 2 1084 7 2877235 10.1016/S0140-6736(86)90478-2 1:STN:280:DyaL2s%2FjvVertQ%3D%3D Hawkey CJ, Walt RP. Prostaglandins for peptic ulcer. A promise unfulfilled. Lancet. 1986;2:1084–7.
17. 17. G Dorta D Nicolet D Vouillamoz D Margalith Al Blum D Armstrong 1996 Effects of misoprostol on healing and prevention of biopsy-induced gastroduodenal lesions occuring during the administration of diclofenac in volunteers Aliment Pharmacol Ther 10 563 9 8853760 10.1046/j.1365-2036.1996.29171000.x 1:CAS:528:DyaK28Xltlaisbc%3D Dorta G, Nicolet D, Vouillamoz D, Margalith D, Blum Al, Armstrong D. Effects of misoprostol on healing and prevention of biopsy-induced gastroduodenal lesions occuring during the administration of diclofenac in volunteers. Aliment Pharmacol Ther 1996;10:563–9.
18. 18. A Walan JP Bader M Classen 1989 Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer N Engl J Med 320 69 75 2643037 1:STN:280:DyaL1M%2FpslWjsg%3D%3D 10.1056/NEJM198901123200201 Walan A, Bader JP, Classen M et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med 1989;320:69–75.
19. 19. JY Wang H Nagai S Okabe 1990 Effect of omeprazole on delayed healing of acetic acid-induced gastric ulcers in rats Jpn J Pharmacol 54 82 5 2273651 1:CAS:528:DyaK3cXls1Ghtr8%3D Wang JY, Nagai H, Okabe S. Effect of omeprazole on delayed healing of acetic acid-induced gastric ulcers in rats. Jpn J Pharmacol. 1990;54:82–5.
20. 20. SP Sirko R Schindler MJ Doyle SM Weisman CA Dinarello 1991 Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor Eur J Immunol 21 243 50 1847874 10.1002/eji.1830210202 1:CAS:528:DyaK3MXhsVWhtb8%3D Sirko SP, Schindler R, Doyle MJ, Weisman SM, Dinarello CA. Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor. Eur J Immunol. 1991;21:243–50.
21. 21. Halter F, Rainsford KD, Sirko SS, Schmassmann A. NSAID-induced mucosal injury: analysis of gastric toxicity of new generation NSAIDs: ulcerogenicity compared with ulcer healing. Yale J Biol Med. (in press).
22. 22. JL Wallace B Reuter C Cicala W McKnight MB Grisham G Cirino 1994 Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat Gastroenterology 107 173 9 8020659 1:CAS:528:DyaK2cXmslWmtbw%3D Wallace JL, Reuter B, Cicala C, McKnight W, Grisham MB, Cirino G. Novel nonsteroidal anti-inflammatory drug derivatives with markedly reduced ulcerogenic properties in the rat. Gastroenterology. 1994;107:173–9.
23. 23. SN Elliott W McKnight G Cirino JL Wallace 1995 A nitri oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats Gastroenterology 109 524 30 7615202 10.1016/0016-5085(95)90341-0 1:CAS:528:DyaK2MXntlCgtb8%3D Elliott SN, McKnight W, Cirino G, Wallace, JL. A nitri oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology. 1995;109:524–30.
24. 24. SN Elliott W McKnight G Cirino JL Wallace 1995 A nitric oxide-releasing nonsteroidal anti-inflammatory drugs Agents Actions 46 121 9 Elliott SN, McKnight W, Cirino G, Wallace JL. A nitric oxide-releasing nonsteroidal anti-inflammatory drugs. Agents Actions. 1995;46:121–9.
25. 25. G Benoni M Terzi A Adami L Grigolini P Soldato Del L Cuzzolin 1995 Plasma concentrations and pharmacokinetic parameters of nitrofenac using a simple and sensitive HPLC method J Pharm Sci. 84 93 5 7714752 10.1002/jps.2600840121 1:CAS:528:DyaK2MXis1Clsr4%3D Benoni G, Terzi M, Adami A, Grigolini L, Del Soldato P, Cuzzolin L. Plasma concentrations and pharmacokinetic parameters of nitrofenac using a simple and sensitive HPLC method. J Pharm Sci. 1995;84:93–5.
26. 26. JL Wallace B Reuter C Cicala W McKnight M Grisham G Cirino 1994 A diclofenac derivative without ulcerogenic properties Eur J Pharmacol 25 249 55 10.1016/0014-2999(94)90136-8 Wallace JL, Reuter B, Cicala C, McKnight W, Grisham M, Cirino G. A diclofenac derivative without ulcerogenic properties. Eur J Pharmacol. 1994;25:249–55.
27. 27. A Conforti M Donini G Brocco P Soldato Del G Benoni L Cuzzolin 1993 Acute anti-inflammatory activity and gastrointestinal tolerability of diclofenac and nitrofenac Agents Actions 40 176 80 8023740 10.1007/BF01984058 1:CAS:528:DyaK2cXis1SrsL0%3D Conforti A, Donini M, Brocco G, DelSoldato P, Benoni G, Cuzzolin L. Acute anti-inflammatory activity and gastrointestinal tolerability of diclofenac and nitrofenac. Agents Actions. 1993;40:176–80.
28. 28. BK Reuter G Cirino JL Wallace 1994 Markedly reduced intestinal toxicity of a diclofenac derivative Life Sci 55 1 8 10.1016/0024-3205(94)90083-3 Reuter BK, Cirino G, Wallace JL. Markedly reduced intestinal toxicity of a diclofenac derivative. Life Sci 1994;55:1–8.
29. 29. L Cuzzolin A Conforti M Donini A Adami P Soldato Del G Benoni 1994 Effects on intestinal microflora, gastrointestinal tolerability and antiinflammatory efficacy of diclofenac and nitrofenac in adjuvant arthritic rats Pharmacol Res. 29 89 97 8202446 10.1016/1043-6618(94)80101-0 1:CAS:528:DyaK2cXkslehu70%3D Cuzzolin, L, Conforti A, Donini M, Adami A, Del Soldato P, Benoni G. Effects on intestinal microflora, gastrointestinal tolerability and antiinflammatory efficacy of diclofenac and nitrofenac in adjuvant arthritic rats. Pharmacol Res. 1994;29:89–97.
30. 30. GJ Roth CJ Siok J Ozols 1980 Structural characteristics of prostaglandin synthase from sheep vesicular gland J Biol Chem 255 1301 4 6766446 1:CAS:528:DyaL3cXhsVagur8%3D Roth GJ, Siok CJ, Ozols J. Structural characteristics of prostaglandin synthase from sheep vesicular gland. J Biol Chem. 1980;255:1301–4.
31. 31. CS Williams RN Dubois 1996 Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol 270 G393 G400 8638704 1:CAS:528:DyaK28XitVajurw%3D Williams CS, Dubois RN: Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol. 1996;270:G393-G400.
32. 32. S Boyce CC Chan R Gordon 1994 L-745,337: A selective inhibitor of cyclo-oxygenase-2 elicits antinociception but not gastric ulceration in rats Neuropharmacology 33 1609 11 7760984 10.1016/0028-3908(94)90137-6 1:CAS:528:DyaK2MXjsVyrtrc%3D Boyce S, Chan CC, Gordon R et al. L-745,337: A selective inhibitor of cyclo-oxygenase-2 elicits antinociception but not gastric ulceration in rats. Neuropharmacology. 33;1994;1609–11.
33. 33. CC Chan S Boyce C Brideau 1995 Pharmacology of a selective oxygenase-2 inhibitor, L-745, 337: A novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach J Pharmacol Exp Ther 274 1531 7 7562530 1:CAS:528:DyaK2MXot1yjtL0%3D Chan CC, Boyce, S, Brideau C et al. Pharmacology of a selective oxygenase-2 inhibitor, L-745, 337: A novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J Pharmacol Exp Ther. 1995;274:1531–7.
34. 34. A Schmassmann A Tarnawski BM Peskar L Varga B Flogerzi F Halter 1995 Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin Am J Physiol 268 G276 85 7532364 1:CAS:528:DyaK2MXktFGnt7Y%3D Schmassmann A, Tarnawski A, Peskar BM, Varga L, Flogerzi B, Halter F. Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin. Am J Physiol. 1995;268:G276–85.
35. 35. A Schmassmann P Netzer B Flogerzi F Halter 1997 Role of cyclooxygenase-1 and-2 in gastric ulcer healing in rats Gastroenterology 112A 283 283 Schmassmann A, Netzer P, Flogerzi B, Halter F. Role of cyclooxygenase-1 and-2 in gastric ulcer healing in rats. Gastroenterology. 1997;112A:283.
36. 36. A Tarnawski K Wahlstrom H Gergely IJ Sarfeh 1996 Expression of cyclooxygenase-1 and-2 (COX-1 and COX-2) in normal gastric mucosa. Effect of antacid (hydrotalcit) treatment Gastroenterology 110 A275 A275 10.1053/gast.1996.v110.pm8536868 Tarnawski A, Wahlstrom K, Gergely H, Sarfeh IJ. Expression of cyclooxygenase-1 and-2 (COX-1 and COX-2) in normal gastric mucosa. Effect of antacid (hydrotalcit) treatment. Gastroenterology. 1996;110:A275.
37. 37. H Mizuno C Sakamoto K Matusda 1997 Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice Gastroenterology 112 387 97 9024292 10.1053/gast.1997.v112.pm9024292 1:CAS:528:DyaK2sXhsVKht7g%3D Mizuno H, Sakamoto C, Matusda K et al. Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology. 1997;112:387–97.